News
Averting and Treating Immune-related Adverse Events Associated with Checkpoint Immunotherapies
14 June 2021 In Science, Treatment
Checkpoint inhibitors are therapies that empower the immune system to kill cancer cells. However, sometimes immune-related adverse events (irAE) can also occur as a result. To help overcome this challenge, MRA has issued a number of research grants, including some in partnership with the American Cancer Society (ACS) and the Society for Immunotherapy of Cancer (SITC), to support an array of approaches.
Advancing Melanoma Research in Times of Uncertainty
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 9 June 2021 In Allies & Partnerships, Melanoma Stories, Policy, Prevention, Science, Treatment
Each year, the annual MRA Scientific Retreat brings hundreds of people from across the melanoma research ecosystem together to exchange ideas, report on scientific progress, celebrate achievements, and mourn the losses. In these ways, the 2021 Retreat was no different.
Separating Hope From Hype in Melanoma Research
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 4 June 2021 In Science, Treatment
In the last decade alone 13 therapeutic approaches have earned FDA approval giving patients, families, and clinicians new tools to treat melanoma. But there can be a fine line between hope and hype, especially today when news — both true and inflated — travels instantly via the internet and social media.
MRA's Acral Melanoma Cell Line Catalog: A Launching Pad for Research
By Raj Talukdar, MRA Science Intern | 25 May 2021 In Science
In a collaborative effort to facilitate research focused on acral melanoma, MRA has created and annotated a catalog of acral melanoma cell lines from various institutions worldwide. The catalog includes cell lines created by researchers at Memorial Sloan Kettering Cancer Center, Wistar Institute, Yale University, the University of Zurich, the Queensland Institute of Medical Research in Australia and more.
Turning Memory Into Action: Honoring Her Father and Raising Awareness
By Renee Orcione, MRA Digital Engagement & Communications Manager | 24 May 2021
In 2021, 7,180 people are estimated to lose their lives due to melanoma in the United States alone. That’s 7,180 individuals – fathers, mothers, daughters, sons, partners and more – gone but for the impact they had, and the memories and loved ones that they left behind. Those left behind, be it family...
Firming the Foundation: Pathology, Rare Melanomas, and Moving the Field Forward
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 21 May 2021 In Science, Treatment
When Dr. Priyadharsini Nagarajan talks about her work at MD Anderson Cancer Center, her energy and excitement could light up any room. That’s because Dr. Nagarajan – a pathologist who specializes in skin (called a ‘dermatopathologist’) – sees her work as critical to creating a firm foundation for all subsequent...
SPOTMYUV: Your Sunscreen’s New Best Friend
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 20 May 2021 In Allies & Partnerships, Prevention
SPOTMYUV, a small, water-resistant sticker applied to any skin exposed to direct sunlight such as your arm or shoulder, helps the wearer know when it is time to reapply their sunscreen by changing color. Throughout the day, a SPOT sticker works to absorb the sunscreen’s UV protecting ingredients at about the same rate as your skin. The SPOT is clear when you are protected by your sunscreen and quickly turns into a deep purple as the sunscreen loses its effectiveness. By monitoring the SPOT, you get a real-time way to monitor your sunscreen without chancing sunburn.
Melanoma Research Alliance Announces $8.1 million in Research Awards
By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 27 April 2021 In News, Prevention, Science, Treatment
The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards. The awards, issued on the cusp of Melanoma Awareness Month, provide critical funding to address urgent unmet needs in melanoma.
A New Treatment Approach in the Arsenal: Neoadjuvent Therapy
23 April 2021 In Allies & Partnerships, News, Science, Treatment
Surgery is the backbone of melanoma treatment and is curative for the vast majority of patients with localized melanoma. However, even if surgery successfully removes all detectible traces of tumor tissue, some patients will still experience a melanoma relapse. Can neoadjuvant therapy, an experimental approach, reduce the risk of recurrence?
Against the Odds: Racing for Melanoma Research
19 April 2021 In Allies & Partnerships, Melanoma Stories, Treatment
Patrick O’Neill along with his four closest college friends and fellow Boat Racing, LLC members, find themselves in a very implausible position: first-time horse owners heading to the Kentucky Derby—horseracing’s pinnacle event.